ProCE Banner Activity

Breast Cancer: A Look Ahead to Practice-Changing Data at the 2016 Clinical Oncology Meeting

Conference Coverage
Clinical Thought
Here are the breast cancer abstracts that I am most interested in hearing about at this year’s ASCO annual meeting.

Released: May 31, 2016

Expiration: May 30, 2017

No longer available for credit.

Share

Faculty

Sara Hurvitz

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Amgen, Inc.

Ariad

Bayer Healthcare Pharma

Celgene

Genentech Roche Virology

Incyte

Merck Oncology

Taiho Pharmaceuticals

Faculty Disclosure

Primary Author

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Sara Hurvitz, MD, has disclosed that she has received funds for research support from Amgen, Bayer, Biomarin, Dignitana, Genentech, GlaxoSmithKline, Lilly, Medivation, Merrimack, Novartis, OBI Pharma, Pfizer, PUMA, and Roche.